Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial
Peter Aaby; Cesário Martins; M.‐L. Garly; C. Bale; Andreas Andersen; Amabélia Rodrigues; Henrik Ravn; Ida Maria Lisse · 2010 · BMJ
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract (excerpt)
OBJECTIVE: To examine in a randomised trial whether a 25% difference in mortality exists between 4.5 months and 3 years of age for children given two standard doses of Edmonston-Zagreb measles vaccines at 4.5 and 9 months of age compared…
Excerpt shown for reference under fair use — read the full paper at the publisher.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level
Negative / Null Result ReportDamaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
Negative / Null Result ReportBCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
Negative / Null Result ReportEffects of Bacillus subtilis on the growth performance, digestive enzymes, immune gene expression and disease resistance of white shrimp, Litopenaeus vannamei
Negative / Null Result ReportFucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease
Negative / Null Result ReportGlobal Population Structure and Evolution of Bordetella pertussis and Their Relationship with Vaccination
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: OpenAlex · DOI 10.1136/bmj.c6495